Research interfacing chemical biology with the -omic sciences and systems biology.
Impact Factor 3.35 12 Issues per Year Indexed in MEDLINE
Opinion

Hypothesis: butyrate is not an HDAC inhibitor, but a product inhibitor of deacetylation

Show Affiliations
Hide Affiliations
*
Corresponding authors
a
Molecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology, University of Sheffield, Beech Hill Road, Sheffield, UK
E-mail: b.m.corfe@sheffield.ac.uk ;
Tel: +44 (0)114 271 3004
Mol. BioSyst., 2012,8, 1609-1612

DOI: 10.1039/C2MB25028D
Received 24 Jan 2012, Accepted 23 Feb 2012
First published online 28 Feb 2012
| | | | | | More
Please wait while Download options loads
Download Citation